PURPOSE: Electrographic seizures (ES) and electrographic status epilepticus (ESE) are common in encephalopathic children in the pediatric intensive care unit (PICU) and associated with worse short-term outcome. Survey data indicate most physicians treat ES and ESE with antiepileptic drugs (AEDs), but few data are available regarding AED usage patterns. We aimed to describe AED usage for ES and ESE in critically ill children. METHODS: We performed an observational study of patients who underwent continuous electroencephalographic (cEEG) monitoring in the PICU of a single quaternary care children's hospital. We collected data regarding age, clinical diagnoses, ES and ESE occurrence, and AEDs utilized. RESULTS: 200 subjects underwent cEEG. ES occurred in 21% (41/200) and ESE occurred in 22% (43/200). Of the 84 patients with ES or ESE, 80 received non-benzodiazepine AEDs including 48% (38 of 80) with ES and 52% (42 of 80) with ESE. The most commonly administered first AEDs were levetiracetam in 38% (30/80), phenobarbital in 31% (25/80), phenytoin-fosphenytoin in 28% (22/80), and valproate in 4% (3/80). Seizures terminated after administration of the first AED in 74% (28/38) with ES and 22% (9/41) with ESE. CONCLUSIONS: Levetiracetam, phenobarbital, and phenytoin-fosphenytoin are commonly used to manage ES and ESE at our center. Over half of subjects received multiple AEDs.
PURPOSE: Electrographic seizures (ES) and electrographic status epilepticus (ESE) are common in encephalopathic children in the pediatric intensive care unit (PICU) and associated with worse short-term outcome. Survey data indicate most physicians treat ES and ESE with antiepileptic drugs (AEDs), but few data are available regarding AED usage patterns. We aimed to describe AED usage for ES and ESE in critically ill children. METHODS: We performed an observational study of patients who underwent continuous electroencephalographic (cEEG) monitoring in the PICU of a single quaternary care children's hospital. We collected data regarding age, clinical diagnoses, ES and ESE occurrence, and AEDs utilized. RESULTS: 200 subjects underwent cEEG. ES occurred in 21% (41/200) and ESE occurred in 22% (43/200). Of the 84 patients with ES or ESE, 80 received non-benzodiazepine AEDs including 48% (38 of 80) with ES and 52% (42 of 80) with ESE. The most commonly administered first AEDs were levetiracetam in 38% (30/80), phenobarbital in 31% (25/80), phenytoin-fosphenytoin in 28% (22/80), and valproate in 4% (3/80). Seizures terminated after administration of the first AED in 74% (28/38) with ES and 22% (9/41) with ESE. CONCLUSIONS:Levetiracetam, phenobarbital, and phenytoin-fosphenytoin are commonly used to manage ES and ESE at our center. Over half of subjects received multiple AEDs.
Authors: Dale Halsey Lea; Judith L Johnson; Sara Ellingwood; Walter Allan; Arvind Patel; Rosemarie Smith Journal: Genet Med Date: 2005-01 Impact factor: 8.822
Authors: Sarah M Sanchez; Jessica Carpenter; Kevin E Chapman; Dennis J Dlugos; William B Gallentine; Christopher C Giza; Joshua L Goldstein; Cecil D Hahn; Sudha K Kessler; Tobias Loddenkemper; James J Riviello; Nicholas S Abend Journal: J Clin Neurophysiol Date: 2013-04 Impact factor: 2.177
Authors: Stacey K H Tay; Lawrence J Hirsch; Linda Leary; Nathalie Jette; John Wittman; Cigdem I Akman Journal: Epilepsia Date: 2006-09 Impact factor: 5.864
Authors: Iván Sánchez Fernández; Nicholas S Abend; Daniel H Arndt; Jessica L Carpenter; Kevin E Chapman; Karen M Cornett; Dennis J Dlugos; William B Gallentine; Christopher C Giza; Joshua L Goldstein; Cecil D Hahn; Jason T Lerner; Joyce H Matsumoto; Kristin McBain; Kendall B Nash; Eric Payne; Sarah M Sánchez; Korwyn Williams; Tobias Loddenkemper Journal: J Pediatr Date: 2013-10-22 Impact factor: 4.406
Authors: Nicholas S Abend; Katherine L Wagenman; Taylor P Blake; Maria T Schultheis; Jerilynn Radcliffe; Robert A Berg; Alexis A Topjian; Dennis J Dlugos Journal: Epilepsy Behav Date: 2015-04-20 Impact factor: 2.937
Authors: France W Fung; Marin Jacobwitz; Lisa Vala; Darshana Parikh; Maureen Donnelly; Rui Xiao; Alexis A Topjian; Nicholas S Abend Journal: Epilepsia Date: 2019-09-20 Impact factor: 5.864
Authors: Katherine L Wagenman; Taylor P Blake; Sarah M Sanchez; Maria T Schultheis; Jerilynn Radcliffe; Robert A Berg; Dennis J Dlugos; Alexis A Topjian; Nicholas S Abend Journal: Neurology Date: 2014-01-02 Impact factor: 9.910
Authors: France W Fung; Jiaxin Fan; Lisa Vala; Marin Jacobwitz; Darshana S Parikh; Maureen Donnelly; Alexis A Topjian; Rui Xiao; Nicholas S Abend Journal: Neurology Date: 2020-07-20 Impact factor: 9.910
Authors: Jian Hu; France W Fung; Marin Jacobwitz; Darshana S Parikh; Lisa Vala; Maureen Donnelly; Alexis A Topjian; Nicholas S Abend; Rui Xiao Journal: Seizure Date: 2021-03-04 Impact factor: 3.184
Authors: France W Fung; Zi Wang; Darshana S Parikh; Marin Jacobwitz; Lisa Vala; Maureen Donnelly; Alexis A Topjian; Rui Xiao; Nicholas S Abend Journal: Neurology Date: 2021-04-23 Impact factor: 11.800